Becton Dickinson & Co. closed 32.13% below its 52-week high of $251.99, which the company reached on February 3rd.

Becton, Dickinson and Company ( NYSE: BDX) Bank of America Securities Health Care Conference Call May 13, 2025 1:00 PM ET Tom Polen - Chairman, Chief Executive Officer and President ...

Becton Dickinson receives multiple downgrades as analysts cite weakening organic growth and trimmed price targets following a ...

Merck will have early-stage opportunities to help startups set up for future success in the pharmaceutical and life sciences fields.

Even though Becton, Dickinson and Company (NYSE:BDX) posted strong earnings, investors appeared to be underwhelmed. We have done some analysis and have found some comforting factors beneath the ...

Fintel reports that on May 2, 2025, Piper Sandler downgraded their outlook for Becton, Dickinson and (NYSE:BDX) from ...

Over 300 people are undergoing a precautionary “decontamination” process after a suspicious package incident at the Becton ...

Shares of Becton Dickinson & Co. BDX advanced 4.86% to $175.34 Monday, on what proved to be an all-around great trading session for the stock market, with the S&P 500 Index SPX rising 3.26% to ...

″‘Buying the dip’ depends upon your timeframe,” says Richard Smith, CEO of investing tool RiskSmith. “If you can keep your ...

Wells Fargo & Company downgraded shares of Becton, Dickinson and Company (NYSE:BDX – Free Report) from an overweight rating to an equal weight rating in a report released on Thursday ...

Becton Dickinson recently announced mixed second-quarter financial results with increased sales but lower net income and EPS. Despite raising its earnings guidance slightly, the company's stock ...

"Jeff is a visionary leader with a strong track record of driving global success in the life sciences and medical device industries," said Jay Katzen, Executive Chairman, Fotona. "We are excited to ...